Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

China continues to boost pharmaceutical innovation through regulatory reforms and as a result, "the pace of new drug ...

A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two ...

The University of Kentucky's Center for Clinical and Translational Science brought together around 1,000 clinicians, ...

The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...

A team of chemists, biologists and microbiologists led by researchers in Arts & Sciences at Washington University in St.

Every few days, doctors needed to drain liters of fluid ... There isn’t typically much money to be made developing a new drug ...

When it comes to antibiotic stewardship and clinical care, Brad Spellberg, MD, just wants to see the data.